Suboptimal use of oral anticoagulants in atrial fibrillation: Has the introduction of direct oral anticoagulants improved prescribing practices?

QR Code

Suboptimal use of oral anticoagulants in atrial fibrillation: Has the introduction of direct oral anticoagulants improved prescribing practices?

© Springer International Publishing Switzerland 2016.Background and Objectives: Atrial fibrillation (AF) and the associated risk of stroke are emerging epidemics throughout the world. Suboptimal use of oral anticoagulants for stroke prevention has been widely reported from observational studies. In...

Full description

Bibliographic Details
Main Authors:	Alamneh, E., Stafford, Leanne, Bereznicki, L.
Format:	Journal Article
Published:	2016
Online Access:	http://hdl.handle.net/20.500.11937/58608

Similar Items

The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
by: Alamneh, E., et al.
Published: (2017)

Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016)

Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018)

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
by: Obamiro, K., et al.
Published: (2016)

Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018)

The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation
by: Rolls, C., et al.
Published: (2017)

Systematic review of adherence to direct oral anticoagulants in patients with atrial fibrilation in clinical practice
by: Kubas, Mohammed Abdullah, et al.
Published: (2018)

Development and validation of an oral anticoagulation knowledge tool (AKT)
by: Obamiro, K., et al.
Published: (2016)

Assessing adherence to direct oral anticoagulants (DOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia
by: Kubas, Mohammed Abdullah, et al.
Published: (2019)

Association between use of non–vitamin k oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation
by: Chang, Shang-Hung, et al.
Published: (2017)

Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Assessing adherence and persistence to non-vitamin k antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia
by: Kubas, Mohammed A., et al.
Published: (2020)

Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
by: Bista, D., et al.
Published: (2017)

Anticoagulant therapy in the elderly: the importance of health literacy.
by: Peterson, G., et al.
Published: (2012)

Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registry
by: Fauchier, L., et al.
Published: (2015)

Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
by: Admassie, E., et al.
Published: (2018)

Incidence of major bleeding among oral anticoagulants / Ziran Nadiah Ghazali
by: Ghazali, Ziran Nadiah
Published: (2017)

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
by: Vinogradova, Yana, et al.
Published: (2018)

Anticoagulant activity of coumarin derivatives
by: Haziri, Arben, et al.
Published: (2022)

Anticoagulation in CRRT: Agents and strategies in Australian ICUs
by: Davies, Hugh, et al.
Published: (2007)

Maintaining the CRRT Circuit: Non anticoagulant alternatives.
by: Davies, H., et al.
Published: (2006)

Bioactive extract having blood anticoagulant activity.
by: Abdullah, Janna Ong, et al.
Published: (2008)

Maleic acid 3-methyl-2-pyridylamide eliciting direct anticoagulant effect
by: Kolotova, N., et al.
Published: (2007)

Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)

Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)

Protocol to assess the effectiveness and safety of novel oral anticoagulants (NOAC) vs warfarin in real world settings: cohort study in primary care
by: Hippisley-Cox, Julia, et al.
Published: (2016)

Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence
by: Gebreyohannes, Eyob Alemayehu, et al.
Published: (2020)

Treatment of anticoagulated patients with negative pressure wound therapy
by: Boxall, S., et al.
Published: (2017)

A rare case of vein of galen thrombosis: exploring a potential role for novel oral anticoagulants (NOACs) in cerebral deep vein thrombosis
by: Inche Mat, Liyana Najwa, et al.
Published: (2017)

Beyond anticoagulant: heparin as a potential anti-cancer agent
by: Lokwani, Ravi, et al.
Published: (2014)

Beyond anticoagulant : Heparin as a potential anti-cancer agent
by: Ravi, Lokwani, et al.
Published: (2014)

Evaluation of anticoagulant property of aqueous and Ethanolic Extracts of Morinda citrifolia
by: Abdul Karim, Mohd Arif, et al.
Published: (2013)

ENVIRONMENTAL SUSTAINABILITY APPRAISAL OF THE ATRIAL FIBRILLATION CARE PATHWAY
by: Munawar, Sana
Published: (2016)

Has COVID-19 improved public awareness on oral hygiene?
by: Sorooshian, Shahryar, et al.
Published: (2021)

Paraoxonase-1 (PON1) activity in serum and various anticoagulated-plasma
by: Abdullah, Nor Zamzila, et al.
Published: (2012)

Paraoxonase-1 (PON1) activity in serum and various anticoagulated-plasma
by: Abdullah, Nor Zamzila, et al.
Published: (2012)

Extensive rectus sheath hematoma secondary to erroneous technique of anticoagulant injection
by: Hassan S,, et al.
Published: (2018)

Glycosaminoglycans from plant sources and the potential uses as anticoagulant and anticancer agents
by: Che Nur Mazadillina, Che Zahari, et al.
Published: (2019)

Anticoagulant activity of polyphenolic-polysaccharides isolated from Melastoma malabathricum L.
by: Khoo, Li Teng, et al.
Published: (2014)